BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25229333)

  • 21. Folylpolyglutamate synthetase gene transcription is regulated by a multiprotein complex that binds the TEL-AML1 fusion in acute lymphoblastic leukemia.
    Leclerc GJ; Sanderson C; Hunger S; Devidas M; Barredo JC
    Leuk Res; 2010 Dec; 34(12):1601-9. PubMed ID: 20538338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analysis of murine leukemia cell lines resistant to 5, 10-dideazatetrahydrofolate identifies several amino acids critical to the function of folylpolyglutamate synthetase.
    Zhao R; Titus S; Gao F; Moran RG; Goldman ID
    J Biol Chem; 2000 Aug; 275(34):26599-606. PubMed ID: 10856298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in the expression of transcription factors and the reduced folate carrier as a novel mechanism of antifolate resistance in human leukemia cells.
    Rothem L; Aronheim A; Assaraf YG
    J Biol Chem; 2003 Mar; 278(11):8935-41. PubMed ID: 12519783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis.
    Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
    Oncogene; 2001 Jan; 20(1):88-96. PubMed ID: 11244507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folylpoly-gamma-glutamate synthetase gene mRNA splice variants and protein expression in primary human leukemia cells, cell lines, and normal human tissues.
    Leclerc GJ; Barredo JC
    Clin Cancer Res; 2001 Apr; 7(4):942-51. PubMed ID: 11309345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemia.
    Yu SL; Zhang H; Ho BC; Yu CH; Chang CC; Hsu YC; Ni YL; Lin KH; Jou ST; Lu MY; Chen SH; Wu KH; Wang SC; Chang HH; Pui CH; Yang JJ; Zhang J; Lin DT; Lin SW; Ma X; Yang YL
    Sci Rep; 2020 Jul; 10(1):12074. PubMed ID: 32694622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of genetic variation in the folylpolyglutamate synthase gene.
    Leil TA; Endo C; Adjei AA; Dy GK; Salavaggione OE; Reid JR; Ames MM; Adjei AA
    Cancer Res; 2007 Sep; 67(18):8772-82. PubMed ID: 17875718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue-specific expression of functional isoforms of mouse folypoly-gamma-glutamae synthetase: a basis for targeting folate antimetabolites.
    Turner FB; Andreassi 2nd JL; Ferguson J; Titus S; Tse A; Taylor SM; Moran RG
    Cancer Res; 1999 Dec; 59(24):6074-9. PubMed ID: 10626793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia.
    Rots MG; Pieters R; Peters GJ; Noordhuis P; van Zantwijk CH; Kaspers GJ; Hählen K; Creutzig U; Veerman AJ; Jansen G
    Blood; 1999 Mar; 93(5):1677-83. PubMed ID: 10029597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
    Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
    Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The mbr-FPGS efficient expression plasmid enhances the sensitivity of Jurkat cells to methotrexate].
    Hu WJ; Sun YJ
    Yi Chuan; 2012 Jun; 34(6):705-10. PubMed ID: 22698741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A bifunctional dihydrofolate synthetase--folylpolyglutamate synthetase in Plasmodium falciparum identified by functional complementation in yeast and bacteria.
    Salcedo E; Cortese JF; Plowe CV; Sims PF; Hyde JE
    Mol Biochem Parasitol; 2001 Feb; 112(2):239-52. PubMed ID: 11223131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and Validation of a Sensitive UHPLC-MS/MS-Based Method for the Analysis of Folylpolyglutamate Synthetase Enzymatic Activity in Peripheral Blood Mononuclear Cells: Application in Rheumatoid Arthritis and Leukemia Patients.
    Muller IB; Lin M; Struys EA; Heydari P; Hebing RCF; Nurmohamed MT; van der Laken C; Lems WF; Cloos J; Jansen G; de Jonge R
    Ther Drug Monit; 2019 Oct; 41(5):598-606. PubMed ID: 31008996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis.
    Fotoohi AK; Assaraf YG; Moshfegh A; Hashemi J; Jansen G; Peters GJ; Larsson C; Albertioni F
    Biochem Pharmacol; 2009 Apr; 77(8):1410-7. PubMed ID: 19426680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of antifolate cytotoxicity: folylpolyglutamate synthetase activity during cellular proliferation and development.
    Barredo J; Moran RG
    Mol Pharmacol; 1992 Oct; 42(4):687-94. PubMed ID: 1435744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular basis for decreased folylpoly-gamma-glutamate synthetase expression in a methotrexate resistant CCRF-CEM mutant cell line.
    Leclerc GJ; York TA; Hsieh-Kinser T; Barredo JC
    Leuk Res; 2007 Mar; 31(3):293-9. PubMed ID: 16884772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of folate and one-carbon metabolism in mammalian cells. I. Folate metabolism in Chinese hamster ovary cells expressing Escherichia coli or human folylpoly-gamma-glutamate synthetase activity.
    Osborne CB; Lowe KE; Shane B
    J Biol Chem; 1993 Oct; 268(29):21657-64. PubMed ID: 8408018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel antifolate suppresses growth of FPGS-deficient cells and overcomes methotrexate resistance.
    van der Krift F; Zijlmans DW; Shukla R; Javed A; Koukos PI; Schwarz LL; Timmermans-Sprang EP; Maas PE; Gahtory D; van den Nieuwboer M; Mol JA; Strous GJ; Bonvin AM; van der Stelt M; Veldhuizen EJ; Weingarth M; Vermeulen M; Klumperman J; Maurice MM
    Life Sci Alliance; 2023 Nov; 6(11):. PubMed ID: 37591722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploitation of folate and antifolate polyglutamylation to achieve selective anticancer chemotherapy.
    McGuire JJ; Tsukamoto T; Hart BP; Coward JK; Kalman TI; Galivan J
    Invest New Drugs; 1996; 14(3):317-23. PubMed ID: 8958187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SKA1 induces de novo MTX-resistance in osteosarcoma through inhibiting FPGS transcription.
    Yu W; Min D; Lin F; Zheng S; Tang L; He A; Hu H; Shen Z
    FEBS J; 2019 Jun; 286(12):2399-2414. PubMed ID: 30851225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.